Search Results

There are 18178 results for: content related to: Burden of Illness and Treatment Patterns for Patients with Fibromyalgia

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome

    Intervention Review

    The Cochrane Library

    Winfried Häuser, Gerard Urrútia, Sera Tort, Nurcan Üçeyler and Brian Walitt

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD010292

  2. Milnacipran for neuropathic pain and fibromyalgia in adults

    Intervention Review

    The Cochrane Library

    Sheena Derry, Dipender Gill, Tudor Phillips and R Andrew Moore

    Published Online : 14 MAR 2012, DOI: 10.1002/14651858.CD008244.pub2

  3. Milnacipran versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Atsuo Nakagawa, Norio Watanabe, Ichiro M Omori, Corrado Barbui, Andrea Cipriani, Hugh McGuire, Rachel Churchill and Toshi A Furukawa

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD006529.pub2

  4. Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain

    British Journal of Pharmacology

    Volume 167, Issue 3, October 2012, Pages: 537–547, S Ohnami, A Kato, K Ogawa, S Shinohara, H Ono and M Tanabe

    Article first published online : 5 SEP 2012, DOI: 10.1111/j.1476-5381.2012.02007.x

  5. You have full text access to this OnlineOpen article
    Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

    British Journal of Pharmacology

    Volume 163, Issue 4, June 2011, Pages: 792–803, A-S Wattiez, F Libert, A-M Privat, S Loiodice, J Fialip, A Eschalier and C Courteix

    Article first published online : 26 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01297.x

  6. ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  7. Effects of Milnacipran on Cardiac Repolarization in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 422–433, Antonia Periclou, Robert H. Palmer, Hongjie Zheng and Charles Lindamood III

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009346059

  8. Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study

    Pain Medicine

    Volume 11, Issue 2, February 2010, Pages: 180–194, Don L. Goldenberg, Daniel J. Clauw, Robert H. Palmer, Philip Mease, Wei Chen and R. Michael Gendreau

    Article first published online : 9 DEC 2009, DOI: 10.1111/j.1526-4637.2009.00755.x

  9. You have full text access to this OnlineOpen article
    Milnacipran, a Well-Tolerated Specific Serotonin and Norepinephrine Reuptake Inhibiting Antidepressant

    CNS Drug Reviews

    Volume 4, Issue 2, June 1998, Pages: 137–148, M. Briley

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.1998.tb00060.x

  10. A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia

    Pain Practice

    Volume 11, Issue 2, March/April 2011, Pages: 120–131, Michael E. Geisser, Robert H. Palmer, R. Michael Gendreau, Yong Wang and Daniel J. Clauw

    Article first published online : 19 JUL 2010, DOI: 10.1111/j.1533-2500.2010.00403.x

  11. Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age

    Human Psychopharmacology: Clinical and Experimental

    Volume 19, Issue 6, August 2004, Pages: 405–408, Shigeru Morishita and Seizaburo Arita

    Article first published online : 21 JUN 2004, DOI: 10.1002/hup.608

  12. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression

    Acta Psychiatrica Scandinavica

    Volume 96, Issue 6, December 1997, Pages: 497–504, E. Leinonen, U. Lepola, H. Koponen, O.-P. Mehtonen and R. Rimon

    Article first published online : 13 NOV 2007, DOI: 10.1111/j.1600-0447.1997.tb09953.x

  13. You have full text access to this OnlineOpen article
    Effects of Milnacipran and Pindolol on Extracellular Noradrenaline and Serotonin Levels in Guinea Pig Hypothalamus

    Journal of Neurochemistry

    Volume 69, Issue 2, August 1997, Pages: 815–822, Chantal Moret and Mike Briley

    Article first published online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.69020815.x

  14. Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression

    Human Psychopharmacology: Clinical and Experimental

    Volume 18, Issue 6, August 2003, Pages: 479–482, Shigeru Morishita and Seizaburo Arita

    Article first published online : 17 JUN 2003, DOI: 10.1002/hup.508

  15. Specific serotonin and noradrenaline reuptake inhibitors (SNRIs). A review of their pharmacology, clinical efficacy and tolerability

    Human Psychopharmacology: Clinical and Experimental

    Volume 13, Issue 2, March 1998, Pages: 99–111, M. Briley

    Article first published online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199803)13:2<99::AID-HUP954>3.0.CO;2-2

  16. You have full text access to this OnlineOpen article
    Development of responder definitions for fibromyalgia clinical trials

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 885–894, Lesley M. Arnold, David A. Williams, James I. Hudson, Susan A. Martin, Daniel J. Clauw, Leslie J. Crofford, Fujun Wang, Birol Emir, Chinglin Lai, Rong Zablocki and Philip J. Mease

    Article first published online : 28 FEB 2012, DOI: 10.1002/art.33360

  17. You have full text access to this OnlineOpen article
    Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 62, Issue 9, September 2010, Pages: 2745–2756, Lesley M. Arnold, R. Michael Gendreau, Robert H. Palmer, Judy F. Gendreau and Yong Wang

    Article first published online : 21 MAY 2010, DOI: 10.1002/art.27559

  18. Effects of the novel antidepressant milnacipran in a chronic mild stress model of depression

    Drug Development Research

    Volume 61, Issue 2, February 2004, Pages: 101–106, Mariusz Papp, Emmanuel Panconi and Piotr Gruca

    Article first published online : 19 FEB 2004, DOI: 10.1002/ddr.10340

  19. You have full text access to this OnlineOpen article
    Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients

    Psychiatry and Clinical Neurosciences

    Volume 61, Issue 4, August 2007, Pages: 421–427, SHINGO NAITO, KAZUHIRO SATO, KEIZO YOSHIDA, HISASHI HIGUCHI, HITOSHI TAKAHASHI, MITSUHIRO KAMATA, KENICHI ITO, TADASHI OHKUBO and TETSUO SHIMIZU

    Article first published online : 30 JUN 2007, DOI: 10.1111/j.1440-1819.2007.01679.x

  20. Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

    Human Psychopharmacology: Clinical and Experimental

    Volume 12, Issue S3, September 1997, Pages: S127–S134, Y. Lecrubier

    Article first published online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-1077(199709)12:3+<S127::AID-HUP943>3.0.CO;2-X

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >